Active Clinical Trials

Featured Clinical Trial

We are inviting people who experience sleep disturbances to participate in a clinical research opportunity for a potential treatment.

Currently Recruiting Clinical Trials

New study! We are now recruiting for a new trial that is looking at a potential psychedelic treatment for psychiatric conditions like depression.

This study is investigating a potential new treatment for coeliac disease. There are currently no approved medications available. Register your interest now!

We are inviting people to take part in a study investigating the common cold.

We are currently recruiting for a new clinical trial which is investigating a potential treatment for Irritable Bowel Syndrome (IBS). For those aged between 18 and 65 years old who have diarrhoea predominant IBS.

Receive the annual flu vaccine and an investigational RSV vaccine. A new clinical trial is running throughout Australia for people aged 65 and over, which is investigating a potential vaccine for Respiratory Syncytial Virus (RSV).

We are asking healthy volunteers in Adelaide aged 60-80 to help us investigate a potential new vaccine for Respiratory Syncytial Virus (RSV).

Investigating a potential treatment for women concerned about low sexual libido.

We are inviting people to take part in a clinical study investigating a potential treatment for insomnia. See if you qualify!

Searching for young women interested in participating in healthy volunteer trials conducted by Paratus Clinical Research.

We are inviting people diagnosed with chronic plaque-type psoriasis to participate in a paid clinical research opportunity.

Clinical Trials Coming Soon

Pre-registration is now open for the following studies. Once you have pre-registered, you’ll be among the first to know when recruiting begins!

We are currently inviting people diagnosed with Postherpetic Neuralgia to register their interest in an upcoming medical study.

Recruitment for an upcoming healthy volunteers study is about to begin. This trial will test a new form of inhaled therapy that may be effective in treating Pulmonary Arterial Hypertension.